Report: Conventional antipsychotics could harm elderly

Conventional antipsychotic medications may be even more dangerous than atypical antipsychotics for elderly people with dementia, a new report suggests.

Dr. Philip S. Wang's group at Brigham and Women's Hospital in Boston evaluated data from patients 65 or older who were treated between 1994 and 2003. Data included 9,142 patients who used a conventional antipsychotic drug and 13,748 who used an atypical antipsychotic drug.

In the first 180 days of use, 17.9% of those using a conventional agent (such as Haldol or Thorazine) died, compared with 14.6% of those who used an atypical antipsychotic (such as Zyprexa or Seroquel). Study information is available in the Dec. 1 New England Journal of Medicine.

The U.S. Food and Drug Administration issued an advisory in April that cautioned that the use of atypical antipsychotics increases mortality in the elderly. But it did not include conventional antipsychotics because there was not yet enough trial data, Wang said.

More in News

Provider groups protest MedPAC recommendations to reduce therapy caps

Provider groups protest MedPAC recommendations to reduce therapy ...

Resident care would suffer and providers would shoulder a larger burden if Congress acts on the latest recommendations from the Medicare Payment Advisory Commission, advocates for the long-term care sector ...

Tight timeline forces LTC commission to narrow its ambitions, member says

With its report due by the end of September, the Congressional Long-Term Care Commission is setting its sights on what can be accomplished in an "extraordinarily short time-frame," according to member Judith Stein, executive director of the Center for Medicare Advocacy.

HHS proposes rule to improve consistency of long-term care ombudsman programs

The Department of Health and Human Services' Administration on Aging has proposed a rule to create federal guidelines for long-term care ombudsman programs, to create more uniformity and address questions around ombudsman responsibilities, information disclosure, complaint resolution and conflicts of interest.